vs

Side-by-side financial comparison of Biofrontera Inc. (BFRI) and PURE CYCLE CORP (PCYO). Click either name above to swap in a different company.

Biofrontera Inc. is the larger business by last-quarter revenue ($17.1M vs $9.1M, roughly 1.9× PURE CYCLE CORP). PURE CYCLE CORP runs the higher net margin — 50.0% vs 33.0%, a 17.0% gap on every dollar of revenue. On growth, PURE CYCLE CORP posted the faster year-over-year revenue change (58.8% vs 36.2%). Over the past eight quarters, PURE CYCLE CORP's revenue compounded faster (69.0% CAGR vs 47.0%).

Biofrontera Inc. is a specialty biopharmaceutical enterprise focused on developing and commercializing prescription dermatological products. Its core product line targets skin conditions including actinic keratosis and other dermatological disorders, with primary operating markets in the United States and European Union, serving patients and dermatology care providers.

Pure Cycles, is a bicycle company based in Los Angeles, California that was founded by Michael Fishman, Jordan Schau, Zachary Schau and Austin Stoffers in 2010, as Pure Fix Cycles.

BFRI vs PCYO — Head-to-Head

Bigger by revenue
BFRI
BFRI
1.9× larger
BFRI
$17.1M
$9.1M
PCYO
Growing faster (revenue YoY)
PCYO
PCYO
+22.7% gap
PCYO
58.8%
36.2%
BFRI
Higher net margin
PCYO
PCYO
17.0% more per $
PCYO
50.0%
33.0%
BFRI
Faster 2-yr revenue CAGR
PCYO
PCYO
Annualised
PCYO
69.0%
47.0%
BFRI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BFRI
BFRI
PCYO
PCYO
Revenue
$17.1M
$9.1M
Net Profit
$5.6M
$4.6M
Gross Margin
68.4%
Operating Margin
26.6%
48.0%
Net Margin
33.0%
50.0%
Revenue YoY
36.2%
58.8%
Net Profit YoY
504.0%
16.0%
EPS (diluted)
$0.62
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFRI
BFRI
PCYO
PCYO
Q4 25
$17.1M
$9.1M
Q3 25
$7.0M
$11.2M
Q2 25
$9.0M
$5.1M
Q1 25
$8.6M
$4.0M
Q4 24
$12.6M
$5.8M
Q3 24
$9.0M
$12.6M
Q2 24
$7.8M
$7.6M
Q1 24
$7.9M
$3.2M
Net Profit
BFRI
BFRI
PCYO
PCYO
Q4 25
$5.6M
$4.6M
Q3 25
$-6.6M
$6.1M
Q2 25
$-5.3M
$2.3M
Q1 25
$-4.2M
$809.0K
Q4 24
$-1.4M
$3.9M
Q3 24
$-5.7M
$6.6M
Q2 24
$-257.0K
$2.8M
Q1 24
$-10.4M
$118.0K
Gross Margin
BFRI
BFRI
PCYO
PCYO
Q4 25
68.4%
Q3 25
67.7%
Q2 25
63.4%
Q1 25
38.2%
Q4 24
63.8%
Q3 24
77.8%
Q2 24
64.0%
Q1 24
55.6%
Operating Margin
BFRI
BFRI
PCYO
PCYO
Q4 25
26.6%
48.0%
Q3 25
-89.8%
53.1%
Q2 25
-56.2%
26.0%
Q1 25
-52.9%
-33.2%
Q4 24
-13.6%
29.9%
Q3 24
-55.0%
62.0%
Q2 24
-64.7%
40.3%
Q1 24
-69.1%
-11.5%
Net Margin
BFRI
BFRI
PCYO
PCYO
Q4 25
33.0%
50.0%
Q3 25
-95.1%
54.5%
Q2 25
-59.0%
43.9%
Q1 25
-48.9%
20.3%
Q4 24
-11.1%
68.4%
Q3 24
-62.9%
52.6%
Q2 24
-3.3%
37.2%
Q1 24
-131.9%
3.7%
EPS (diluted)
BFRI
BFRI
PCYO
PCYO
Q4 25
$0.62
$0.19
Q3 25
$-0.62
$0.26
Q2 25
$-0.57
$0.09
Q1 25
$-0.47
$0.03
Q4 24
$0.69
$0.16
Q3 24
$-0.98
$0.27
Q2 24
$-0.05
$0.12
Q1 24
$-2.88
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFRI
BFRI
PCYO
PCYO
Cash + ST InvestmentsLiquidity on hand
$6.4M
$17.1M
Total DebtLower is stronger
$8.0M
Stockholders' EquityBook value
$10.5M
$147.5M
Total Assets
$28.6M
$168.1M
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFRI
BFRI
PCYO
PCYO
Q4 25
$6.4M
$17.1M
Q3 25
$3.4M
$21.9M
Q2 25
$7.2M
$14.4M
Q1 25
$1.8M
$16.5M
Q4 24
$5.9M
$19.0M
Q3 24
$2.9M
$22.1M
Q2 24
$4.4M
$20.5M
Q1 24
$3.8M
$20.6M
Total Debt
BFRI
BFRI
PCYO
PCYO
Q4 25
$8.0M
Q3 25
$6.8M
Q2 25
$6.9M
Q1 25
$6.9M
Q4 24
$6.9M
Q3 24
$6.9M
Q2 24
Q1 24
Stockholders' Equity
BFRI
BFRI
PCYO
PCYO
Q4 25
$10.5M
$147.5M
Q3 25
$-2.6M
$142.7M
Q2 25
$-4.7M
$136.7M
Q1 25
$500.0K
$134.4M
Q4 24
$4.4M
$133.6M
Q3 24
$5.5M
$129.7M
Q2 24
$10.9M
$123.2M
Q1 24
$-5.4M
$120.4M
Total Assets
BFRI
BFRI
PCYO
PCYO
Q4 25
$28.6M
$168.1M
Q3 25
$15.4M
$162.3M
Q2 25
$20.1M
$151.7M
Q1 25
$16.6M
$149.7M
Q4 24
$22.1M
$149.7M
Q3 24
$18.5M
$147.4M
Q2 24
$21.6M
$140.4M
Q1 24
$24.6M
$135.2M
Debt / Equity
BFRI
BFRI
PCYO
PCYO
Q4 25
0.05×
Q3 25
0.05×
Q2 25
0.05×
Q1 25
0.05×
Q4 24
0.05×
Q3 24
0.05×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFRI
BFRI
PCYO
PCYO
Operating Cash FlowLast quarter
$-2.4M
$-979.0K
Free Cash FlowOCF − Capex
$-2.4M
FCF MarginFCF / Revenue
-13.9%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-0.42×
-0.21×
TTM Free Cash FlowTrailing 4 quarters
$-13.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFRI
BFRI
PCYO
PCYO
Q4 25
$-2.4M
$-979.0K
Q3 25
$-3.8M
$9.4M
Q2 25
$-3.0M
$-503.0K
Q1 25
$-4.1M
$-1.4M
Q4 24
$-1.0M
$5.7M
Q3 24
$-1.2M
$3.1M
Q2 24
$-4.7M
$892.0K
Q1 24
$-3.3M
$-457.0K
Free Cash Flow
BFRI
BFRI
PCYO
PCYO
Q4 25
$-2.4M
Q3 25
$-3.8M
Q2 25
$-3.0M
Q1 25
$-4.1M
Q4 24
$-1.0M
Q3 24
Q2 24
$-4.8M
Q1 24
$-3.4M
FCF Margin
BFRI
BFRI
PCYO
PCYO
Q4 25
-13.9%
Q3 25
-54.7%
Q2 25
-33.7%
Q1 25
-48.0%
Q4 24
-8.1%
Q3 24
Q2 24
-60.8%
Q1 24
-42.7%
Capex Intensity
BFRI
BFRI
PCYO
PCYO
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.6%
Q1 24
0.7%
Cash Conversion
BFRI
BFRI
PCYO
PCYO
Q4 25
-0.42×
-0.21×
Q3 25
1.53×
Q2 25
-0.22×
Q1 25
-1.70×
Q4 24
1.44×
Q3 24
0.47×
Q2 24
0.32×
Q1 24
-3.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BFRI
BFRI

Segment breakdown not available.

PCYO
PCYO

Construction$6.5M71%
Water And Wastewater Resource Development Segment$2.5M27%

Related Comparisons